Advanced non-targeted metabolomic testing is revealing the hidden chemical complexity of vape juices. Using GC-MS technology, researchers have identified over 100 distinct compounds in e-liquids and exposed a major industry flaw: the presence of hidden nicotine in products explicitly labeled as nicotine-free.
For years, the vaping industry has leaned on a simple narrative. E-cigarettes are a safer alternative to combustible tobacco because their chemical makeup is far less complex. Instead of inhaling thousands of burning chemicals, users inhale an aerosolized mixture of vegetable glycerin (VG), propylene glycol (PG), food flavorings, and nicotine.
On paper, this sounds straightforward. VG and PG are widely recognized as safe for food consumption. But inhalation is a completely different biological process. Add nicotine—a highly addictive neurotoxin that spikes blood pressure and alters dopamine release in the prefrontal cortex—and the health profile becomes significantly more complicated.
The Flaw in Traditional Vape Testing
Here is the problem with how we have historically tested vape juice. Most scientific studies rely on “targeted analysis.” Researchers go into the lab looking for specific, known villains. They test for volatile organic compounds (VOCs), heavy metals, specific tobacco nitrosamines, and carbonyls.
While this provides valuable toxicological data, it is essentially looking at the e-liquid through a keyhole. It ignores the vast, unknown chemical soup that makes up the rest of the product.
This narrow testing scope has allowed massive quality control issues to slip through the cracks. A glaring example is product mislabeling. In rapidly expanding markets like Malaysia, where product diversity is high and regulations are still catching up, testing frequently reveals a disturbing trend. Liquids marketed and sold specifically as “nicotine-free” actually contain active nicotine. For consumers actively trying to avoid addiction, this lack of manufacturing transparency is a serious threat.
Creating a Chemical Fingerprint
To truly understand what vapers are inhaling, scientists are shifting to a broader strategy: non-targeted metabolomics. Instead of hunting for pre-selected chemicals, this method attempts to identify every small molecule (metabolite) present in a sample. It creates a complete chemical fingerprint of the e-liquid.
The gold standard for this is Gas Chromatography–Mass Spectrometry (GC-MS). When combined with headspace analysis—a technique that focuses specifically on the volatile compounds that evaporate easily—GC-MS allows researchers to separate and identify the exact makeup of a liquid simultaneously.
The results of this non-targeted approach are eye-opening. Recent analyses have detected well over one hundred different compounds within standard e-liquid samples. The chemical diversity between different brands is staggering. Researchers have even identified specific compounds, such as piperonal and tetradecanoic acid ethyl ester, that act as unique chemical markers to distinguish one brand’s formulation from another.
Most importantly, this broad screening confirms the mislabeling crisis, consistently catching hidden nicotine in supposedly zero-nicotine products.
What does this mean for the future of vaping? Right now, metabolomics is an exploratory screening tool. It tells us what is in the bottle, but it does not yet quantify the exact toxicological risk to human lungs. The next step requires larger sample sizes and real-world testing conditions. After all, heating these liquids alters their chemistry, potentially creating entirely new compounds that were not present in the raw liquid. For regulators and public health officials, mapping this chemical complexity is the only way to truly understand the risks of modern vaping.
- Detailed information from this research can be seen in our article at:
Chemistry Africa Journal
https://link.springer.com/article/10.1007/s42250-025-01551-2